Literature DB >> 5041010

Crossed immunoelectrophoresis.

P O Ganrot.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5041010     DOI： 10.3109/00365517209102749

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest Suppl        ISSN： 0085-591X


× No keyword cloud information.
  29 in total

1.  Variants of the group-specific component system as demonstrated by immunofixation electrophoresis. Report of a new variant, Gc Boston (Ge B).

Authors:  A M Johnson; H Cleve; C Alper
Journal:  Am J Hum Genet       Date:  1975-11       Impact factor: 11.025

2.  Circulating monoclonal IgM lambda cryoglobulin with collagen type I affinity in vasculitis.

Authors:  I Clemmensen; B A Jensen; B Hølund; E Kappelgaard; H Neilsen
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

3.  Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes.

Authors:  M L Lokki; S A Koskimies
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  The primary inhibitor of plasmin in human plasma.

Authors:  S Müllertz; I Clemmensen
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

5.  Factor VIII-related antigen in tissues detected by the indirect immunofluorescence technique.

Authors:  R Gruson; C R Rizza
Journal:  Blut       Date:  1974-10

6.  Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.

Authors:  S Müllertz
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

7.  Serological studies of actionomyces israelii by crossed immunoelectrophoresis: standard antigen-antibody system for A. israelii.

Authors:  K Holmberg; C E Nord; T Wadström
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

8.  Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease.

Authors:  W M Canfield; W Kisiel
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

9.  Human coagluation factor V purification and thrombin-catalyzed activation.

Authors:  B Dahlbäck
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.

Authors:  M Bergenfeldt; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.